Predicted to enable mRNA binding activity and protein domain specific binding activity. Predicted to be involved in mRNA cis splicing, via spliceosome and negative regulation of mRNA splicing, via spliceosome. Predicted to act upstream of or within cellular response to leukemia inhibitory factor. Predicted to be located in nucleoplasm. Predicted to be active in nuclear speck. Orthologous to human SRSF7 (serine and arginine rich splicing factor 7).
RGD Description
Predicted to enable mRNA binding activity and protein domain specific binding activity. Predicted to be involved in mRNA cis splicing, via spliceosome and negative regulation of mRNA splicing, via spliceosome. Predicted to act upstream of or within cellular response to leukemia inhibitory factor. Predicted to be located in nucleoplasm. Predicted to be active in nuclear speck. Orthologous to human SRSF7 (serine and arginine rich splicing factor 7); PARTICIPATES IN spliceosome pathway; INTERACTS WITH (+)-schisandrin B; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.